t-butyl 4-{[2-(2-nitrophenyl)ethyl]amino}piperidine-1-carboxylate | 783368-11-6

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 哌啶类
• 英文名称: t-butyl 4-{[2-(2-nitrophenyl)ethyl]amino}piperidine-1-carboxylate
• 英文别名: tert-butyl 4-(2-nitrophenethylamino)piperidine-1-carboxylate；tert-butyl 4-{[2-(2-nitrophenyl)ethyl]amino}piperidine-1-carboxylate；tert-butyl 4-[2-(2-nitrophenyl)ethylamino]piperidine-1-carboxylate
• CAS: 783368-11-6
• 化学式: C₁₈H₂₇N₃O₄
• 分子量: 349.43
• InChiKey: KOZIDQIWLUXUEN-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3
• 重原子数：
  25
• 可旋转键数：
  6
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.61
• 拓扑面积：
  87.4
• 氢给体数：
  1
• 氢受体数：
  5

反应信息

• 作为反应物：
  描述：

  t-butyl 4-{[2-(2-nitrophenyl)ethyl]amino}piperidine-1-carboxylate 在 钯 氢气 作用下， 以 乙醇 为溶剂， 反应 16.0h， 以giving the desired product (9.6 g)的产率得到t-butyl 4-{[2-(2-aminophenyl)ethyl]amino}piperidine-1-carboxylate
  参考文献：
  名称：

  CGRP receptor antagonists

  摘要：

  本发明涉及CGRP受体拮抗剂、其制药组合物以及使用它们治疗CGRP受体介导的疾病和症状的方法。

  公开号：

  US07834000B2
• 作为产物：
  描述：

  2-(2-硝基苯基)乙胺 、 N-叔丁氧羰基-4-哌啶酮 在 sodium cyanoborohydride 、 溶剂黄146 作用下， 以 甲醇 为溶剂， 反应 3.0h， 生成 t-butyl 4-{[2-(2-nitrophenyl)ethyl]amino}piperidine-1-carboxylate
  参考文献：
  名称：

  WO2007/16087

  摘要：

  公开号：

文献信息

• Benzodiazepine cgrp receptor antagonists
  申请人：Burgey S. Christopher

  公开号：US20060148790A1

  公开（公告）日：2006-07-06

  The present invention is directed to compounds of Formula I: (where variables R 1 , R 2 , R 3 , R 6 , R 7 , G, J, W, X and Y are as defined herein) useful as antagonists of CGRP receptors and useful in the treatment or prevention of diseases in which the CGRP is involved, such as headache, migraine and cluster headache. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which CGRP is involved.

  本发明涉及化合物I的公式：（其中变量R1，R2，R3，R6，R7，G，J，W，X和Y的定义如本文所述），用作CGRP受体拮抗剂，并用于治疗或预防CGRP参与的疾病，例如头痛，偏头痛和群头痛。本发明还涉及包含这些化合物的制药组合物以及在预防或治疗CGRP参与的这些疾病中使用这些化合物和组合物的用途。
• Cgrp receptor antagonists
  申请人：Burgey S. Christopher

  公开号：US20060194783A1

  公开（公告）日：2006-08-31

  The present invention is directed to compounds of Formula I and Formula II: (where variables R1, R2, R3, R4, R6, A, B, G, J, W, X and Y are as defined herein) useful as antagonists of CGRP receptors and useful in the treatment or prevention of diseases in which the CGRP is involved, such as headache, migraine and cluster headache. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which CGRP is involved.

  本发明涉及式I和式II的化合物：（其中变量R1、R2、R3、R4、R6、A、B、G、J、W、X和Y如本文所定义），其作为CGRP受体拮抗剂在治疗或预防涉及CGRP的疾病，例如头痛、偏头痛和群发性头痛中有用。本发明还涉及包含这些化合物的制药组合物以及在预防或治疗涉及CGRP的这些疾病中使用这些化合物和组合物的用途。
• Cgrp Receptor Antagonists
  申请人：Paone Daniel V.

  公开号：US20080261972A1

  公开（公告）日：2008-10-23

  Compounds of Formula (I), (where variables R 1 , A, B, W, X, Y and Z are as defined herein) useful as antagonists of CGRP receptors and useful in the treatment or prevention of diseases in which the CGRP is involved, such as headache, migraine and cluster headache. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which CGRP is involved.

  式(I)的化合物（其中变量R1、A、B、W、X、Y和Z如本文所定义），可用作CGRP受体的拮抗剂，并可用于治疗或预防CGRP参与的疾病，如头痛、偏头痛和集群头痛。本发明还涉及包含这些化合物的制药组合物以及使用这些化合物和组合物预防或治疗CGRP参与的这些疾病的方法。
• Benzodiazepine CGRP receptor antagonists
  申请人：Merck & Co, Inc.

  公开号：US07196079B2

  公开（公告）日：2007-03-27

  The present invention is directed to compounds of Formula I: (where variables R1, R2, R3, R6, R7, G, J, W, X and Y are as defined herein) useful as antagonists of CGRP receptors and useful in the treatment or prevention of diseases in which the CGRP is involved, such as headache, migraine and cluster headache. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which CGRP is involved.

  本发明涉及一种化合物，其化学式为I：（其中变量R1、R2、R3、R6、R7、G、J、W、X和Y如本文所定义），该化合物可用作CGRP受体的拮抗剂，可用于治疗或预防CGRP参与的疾病，如头痛、偏头痛和丛集性头痛。本发明还涉及包含这些化合物的制药组合物以及这些化合物和组合物在预防或治疗CGRP参与的这些疾病中的应用。
• Heterocyclic benzodiazepine cgrp receptor antagonists
  申请人：Williams Theresa M.

  公开号：US20090105228A1

  公开（公告）日：2009-04-23

  Compounds of formula I: (where variables R 2 , R 7 , D, W, X, Y and Z are as described herein) which are antagonists of CGRP receptors and which are useful in the treatment or prevention of diseases in which the CGRP is involved, such as migraine. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which CGRP is involved.

  公式I的化合物：（其中变量R2，R7，D，W，X，Y和Z如本文所述），它们是CGRP受体的拮抗剂，并且可用于治疗或预防与CGRP有关的疾病，如偏头痛。本发明还涉及包含这些化合物的制药组合物以及使用这些化合物和组合物预防或治疗CGRP参与的这些疾病。